LAMEA Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Country, Industry Analysis and Forecast, 2020 - 2026
The Latin America, Middle East and Africa Sclerotherapy Market would witness market growth of 8.8% CAGR during the forecast period (2020-2026).
A foam with detergent sclerosants allows a more efficient sclerosant effect by increasing both dwell time and contact area while minimizing the admixture of sclerosant and blood. This increase in efficiency allows lower sclerosants doses. Ultrasound-guided foam sclerotherapy is an upcoming therapy which allows the doctor to monitor the effect of each injection while ensuring the safety of all adjacent structures and effective is more effective as compared to a liquid therapy.
The market has become highly competitive in nature. One of the key factors that is leading to the competitiveness among market players include rapid adoption of advanced technologies such as ultrasound-guided sclerotherapy, and foam therapy. Furthermore, a conspicuous number of these players are swiftly opting for collaborations and strategic expansions for growing their geographical presence and increasing sales volume in evolving and economically encouraging regions.
In the current scenario, more respected hospital is preferring to opt for minimally invasive surgical procedure including Sclerotherapy Treatment. Sclerosing agents that are used for the varicose veins treatment is segmented into detergents, chemical irritants, and hyperosmolar/ osmotic agents.
Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.
Scope of the Study
Market Segmentation:
By Agent
A foam with detergent sclerosants allows a more efficient sclerosant effect by increasing both dwell time and contact area while minimizing the admixture of sclerosant and blood. This increase in efficiency allows lower sclerosants doses. Ultrasound-guided foam sclerotherapy is an upcoming therapy which allows the doctor to monitor the effect of each injection while ensuring the safety of all adjacent structures and effective is more effective as compared to a liquid therapy.
The market has become highly competitive in nature. One of the key factors that is leading to the competitiveness among market players include rapid adoption of advanced technologies such as ultrasound-guided sclerotherapy, and foam therapy. Furthermore, a conspicuous number of these players are swiftly opting for collaborations and strategic expansions for growing their geographical presence and increasing sales volume in evolving and economically encouraging regions.
In the current scenario, more respected hospital is preferring to opt for minimally invasive surgical procedure including Sclerotherapy Treatment. Sclerosing agents that are used for the varicose veins treatment is segmented into detergents, chemical irritants, and hyperosmolar/ osmotic agents.
Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.
Scope of the Study
Market Segmentation:
By Agent
- Detergents
- Osmotic Agents
- Chemical Irritants
- Liquid Sclerotherapy
- Ultrasound Sclerotherapy
- Foam Sclerotherapy
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Boston Scientific Corporation
- Perrigo Company PLC (Omega Pharmaceuticals)
- Cook Medical, Inc. (Cook Group)
- Chemische Fabrik Kreussler & Co. GmbH
- LGM Pharma, LLC
- Troikaa Pharmaceuticals Limited
- Tianyu Chang’an Group
- Endo-Flex GmbH (Meditek Systems)
- Merz Pharma GmbH & Co. KGaA
- MTW-Endoskopie W. Haag KG
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Sclerotherapy Market, by Agent
1.4.2 LAMEA Sclerotherapy Market, by Type
1.4.3 LAMEA Sclerotherapy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA SCLEROTHERAPY MARKET BY AGENT
3.1 LAMEA Detergents Market by Country
3.2 LAMEA Osmotic Agents Market by Country
3.3 LAMEA Chemical Irritants Market by Country
CHAPTER 4. LAMEA SCLEROTHERAPY MARKET BY TYPE
4.1 LAMEA Liquid Sclerotherapy Market by Country
4.2 LAMEA Ultrasound Sclerotherapy Market by Country
4.3 LAMEA Other Type Market by Country
CHAPTER 5. LAMEA SCLEROTHERAPY MARKET BY COUNTRY
5.1 Brazil Sclerotherapy Market
5.1.1 Brazil Sclerotherapy Market by Agent
5.1.2 Brazil Sclerotherapy Market by Type
5.2 Argentina Sclerotherapy Market
5.2.1 Argentina Sclerotherapy Market by Agent
5.2.2 Argentina Sclerotherapy Market by Type
5.3 UAE Sclerotherapy Market
5.3.1 UAE Sclerotherapy Market by Agent
5.3.2 UAE Sclerotherapy Market by Type
5.4 Saudi Arabia Sclerotherapy Market
5.4.1 Saudi Arabia Sclerotherapy Market by Agent
5.4.2 Saudi Arabia Sclerotherapy Market by Type
5.5 South Africa Sclerotherapy Market
5.5.1 South Africa Sclerotherapy Market by Agent
5.5.2 South Africa Sclerotherapy Market by Type
5.6 Nigeria Sclerotherapy Market
5.6.1 Nigeria Sclerotherapy Market by Agent
5.6.2 Nigeria Sclerotherapy Market by Type
5.7 Rest of LAMEA Sclerotherapy Market
5.7.1 Rest of LAMEA Sclerotherapy Market by Agent
5.7.2 Rest of LAMEA Sclerotherapy Market by Type
CHAPTER 6. COMPANY PROFILES
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Sclerotherapy Market, by Agent
1.4.2 LAMEA Sclerotherapy Market, by Type
1.4.3 LAMEA Sclerotherapy Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA SCLEROTHERAPY MARKET BY AGENT
3.1 LAMEA Detergents Market by Country
3.2 LAMEA Osmotic Agents Market by Country
3.3 LAMEA Chemical Irritants Market by Country
CHAPTER 4. LAMEA SCLEROTHERAPY MARKET BY TYPE
4.1 LAMEA Liquid Sclerotherapy Market by Country
4.2 LAMEA Ultrasound Sclerotherapy Market by Country
4.3 LAMEA Other Type Market by Country
CHAPTER 5. LAMEA SCLEROTHERAPY MARKET BY COUNTRY
5.1 Brazil Sclerotherapy Market
5.1.1 Brazil Sclerotherapy Market by Agent
5.1.2 Brazil Sclerotherapy Market by Type
5.2 Argentina Sclerotherapy Market
5.2.1 Argentina Sclerotherapy Market by Agent
5.2.2 Argentina Sclerotherapy Market by Type
5.3 UAE Sclerotherapy Market
5.3.1 UAE Sclerotherapy Market by Agent
5.3.2 UAE Sclerotherapy Market by Type
5.4 Saudi Arabia Sclerotherapy Market
5.4.1 Saudi Arabia Sclerotherapy Market by Agent
5.4.2 Saudi Arabia Sclerotherapy Market by Type
5.5 South Africa Sclerotherapy Market
5.5.1 South Africa Sclerotherapy Market by Agent
5.5.2 South Africa Sclerotherapy Market by Type
5.6 Nigeria Sclerotherapy Market
5.6.1 Nigeria Sclerotherapy Market by Agent
5.6.2 Nigeria Sclerotherapy Market by Type
5.7 Rest of LAMEA Sclerotherapy Market
5.7.1 Rest of LAMEA Sclerotherapy Market by Agent
5.7.2 Rest of LAMEA Sclerotherapy Market by Type
CHAPTER 6. COMPANY PROFILES
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 LAMEA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 3 LAMEA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 4 LAMEA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 5 LAMEA DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 LAMEA DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 LAMEA OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 LAMEA OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 LAMEA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 12 LAMEA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 13 LAMEA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 BRAZIL SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 22 BRAZIL SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 23 BRAZIL SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 24 BRAZIL SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 25 BRAZIL SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 26 BRAZIL SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 27 ARGENTINA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 28 ARGENTINA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 29 ARGENTINA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 30 ARGENTINA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 31 ARGENTINA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 32 ARGENTINA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 33 UAE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 34 UAE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 35 UAE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 36 UAE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 37 UAE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 38 UAE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 39 SAUDI ARABIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 40 SAUDI ARABIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 41 SAUDI ARABIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 42 SAUDI ARABIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 43 SAUDI ARABIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 44 SAUDI ARABIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 45 SOUTH AFRICA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SOUTH AFRICA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SOUTH AFRICA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 48 SOUTH AFRICA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 49 SOUTH AFRICA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 50 SOUTH AFRICA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 51 NIGERIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 52 NIGERIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 53 NIGERIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 54 NIGERIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 55 NIGERIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 56 NIGERIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 57 REST OF LAMEA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 58 REST OF LAMEA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 59 REST OF LAMEA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 60 REST OF LAMEA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 61 REST OF LAMEA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 62 REST OF LAMEA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 63 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 64 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 65 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 66 KEY INFORMATION – CHEMISCHE FABRIK KREUSSLER & CO. GMBH
TABLE 67 KEY INFORMATION – LGM PHARMA, LLC
TABLE 68 KEY INFORMATION – TROIKAA PHARMACEUTICALS LIMITED
TABLE 69 KEY INFORMATION – TIANYU CHANG’AN GROUP
TABLE 70 KEY INFORMATION –ENDO-FLEX GMBH
TABLE 71 KEY INFORMATION – MERZ PHARMA GMBH & CO. KGAA
TABLE 72 KEY INFORMATION – MTW-ENDOSKOPIE W. HAAG KG
TABLE 1 LAMEA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 3 LAMEA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 4 LAMEA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 5 LAMEA DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 LAMEA DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 LAMEA OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 LAMEA OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 LAMEA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 12 LAMEA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 13 LAMEA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 BRAZIL SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 22 BRAZIL SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 23 BRAZIL SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 24 BRAZIL SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 25 BRAZIL SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 26 BRAZIL SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 27 ARGENTINA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 28 ARGENTINA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 29 ARGENTINA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 30 ARGENTINA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 31 ARGENTINA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 32 ARGENTINA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 33 UAE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 34 UAE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 35 UAE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 36 UAE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 37 UAE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 38 UAE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 39 SAUDI ARABIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 40 SAUDI ARABIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 41 SAUDI ARABIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 42 SAUDI ARABIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 43 SAUDI ARABIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 44 SAUDI ARABIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 45 SOUTH AFRICA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SOUTH AFRICA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SOUTH AFRICA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 48 SOUTH AFRICA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 49 SOUTH AFRICA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 50 SOUTH AFRICA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 51 NIGERIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 52 NIGERIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 53 NIGERIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 54 NIGERIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 55 NIGERIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 56 NIGERIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 57 REST OF LAMEA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
TABLE 58 REST OF LAMEA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
TABLE 59 REST OF LAMEA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
TABLE 60 REST OF LAMEA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
TABLE 61 REST OF LAMEA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
TABLE 62 REST OF LAMEA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
TABLE 63 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 64 KEY INFORMATION – PERRIGO COMPANY PLC
TABLE 65 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 66 KEY INFORMATION – CHEMISCHE FABRIK KREUSSLER & CO. GMBH
TABLE 67 KEY INFORMATION – LGM PHARMA, LLC
TABLE 68 KEY INFORMATION – TROIKAA PHARMACEUTICALS LIMITED
TABLE 69 KEY INFORMATION – TIANYU CHANG’AN GROUP
TABLE 70 KEY INFORMATION –ENDO-FLEX GMBH
TABLE 71 KEY INFORMATION – MERZ PHARMA GMBH & CO. KGAA
TABLE 72 KEY INFORMATION – MTW-ENDOSKOPIE W. HAAG KG
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
